{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Sol-Gel Technologies Ltd."},"Symbol":{"label":"Symbol","value":"SLGL"},"Address":{"label":"Address","value":"7 GOLDA MEIR STREET,WEIZMANN SCIENCE PARK, NESS ZIONA, 7403650, Israel"},"Phone":{"label":"Phone","value":"+972 89313429"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Middle East"},"CompanyDescription":{"label":"Company Description","value":"Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications."},"CompanyUrl":{"label":"Company Url","value":"https://www.sol-gel.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alon Seri-Levy","title":"Chief Executive Officer & Director"},{"name":"Itzik Yosef","title":"Chief Operating Officer"},{"name":"Ofer Toledano","title":"Vice President-Research & Development"},{"name":"Ofra Levy-Hacham","title":"VP-Clinical & Regulatory Affairs"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}